Company Filing History:
Years Active: 2025
Title: Innovations of Tommy Li in the Field of Biopharmaceuticals.
Introduction
Tommy Li is an accomplished inventor based in Edison, NJ (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of bispecific antibodies. His work focuses on innovative treatments for diseases, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Tommy Li holds a patent for bispecific antibodies against CD3 and CD20. This invention relates to bispecific antibodies (bsAbs) and their application in treating diseases in subjects. The patent outlines advantageous treatment regimens for B-cell Non-Hodgkin Lymphoma (B-NHL), highlighting the potential impact of his work on cancer therapies.
Career Highlights
Throughout his career, Tommy Li has demonstrated a commitment to innovation in the biopharmaceutical industry. His work at Genmab A/S has positioned him as a key player in the development of novel therapeutic solutions. With a focus on improving patient outcomes, he continues to push the boundaries of what is possible in medical treatment.
Collaborations
Tommy Li collaborates with talented professionals in his field, including Tahamtan Ahmadi and Manish Gupta. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.
Conclusion
Tommy Li's contributions to the field of biopharmaceuticals, particularly through his patent on bispecific antibodies, exemplify his role as an innovative inventor. His work not only advances medical science but also holds promise for improving treatment options for patients with B-cell Non-Hodgkin Lymphoma.